Posterior Scleritis Following COVID-19 Vaccination: A Case Report

ABSTRACT

Purpose

To report a case of posterior scleritis following COVID-19 vaccination.

Study Design

Case report.

Results

A 78-year-old female presented with headache and right-sided visual loss 10 days after the second dose of COVID-19 vaccine. 'Examination showed disc oedema and a serous retinal detachment. B-scan ultrasound showed thickening of the posterior sclera with retroscleral fluid. CT head with venogram excluded venous sinus thrombosis. The patient’s condition improved rapidly with oral corticosteroids with restoration of vision and resolution of disc swelling and serous detachment by 4 weeks.

Conclusions

Posterior scleritis should be considered in patients presenting with headaches and blurred vision following vaccination. Timely diagnosis and treatment with corticosteroids can prevent permanent visual loss.

KEYWORDS:

• Case report
• COVID-19
• COVID-19 vaccination
• posterior scleritis

Disclosure statement

All authors satisfy the ICMJE criteria for authorship.

Authors’ contributions

OY wrote the manuscript with support from UM. All authors discussed and contributed to the final manuscript.

Correction Statement

This article has been corrected with minor changes. These changes do not impact the academic content of the article.

Additional information

Funding

The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.